Literature DB >> 17322893

Rapid SNP diagnostics using asymmetric isothermal amplification and a new mismatch-suppression technology.

Yasumasa Mitani1, Alexander Lezhava, Yuki Kawai, Takeshi Kikuchi, Atsuko Oguchi-Katayama, Yasushi Kogo, Masayoshi Itoh, Toru Miyagi, Hideki Takakura, Kanako Hoshi, Chiaki Kato, Takahiro Arakawa, Kazuhiro Shibata, Kenji Fukui, Ryoji Masui, Seiki Kuramitsu, Kazuma Kiyotani, Alistair Chalk, Katsuhiko Tsunekawa, Masami Murakami, Tetsuya Kamataki, Takanori Oka, Hiroshi Shimada, Paul E Cizdziel, Yoshihide Hayashizaki.   

Abstract

We developed a rapid single nucleotide polymorphism (SNP) detection system named smart amplification process version 2 (SMAP 2). Because DNA amplification only occurred with a perfect primer match, amplification alone was sufficient to identify the target allele. To achieve the requisite fidelity to support this claim, we used two new and complementary approaches to suppress exponential background DNA amplification that resulted from mispriming events. SMAP 2 is isothermal and achieved SNP detection from whole human blood in 30 min when performed with a new DNA polymerase that was cloned and isolated from Alicyclobacillus acidocaldarius (Aac pol). Furthermore, to assist the scientific community in configuring SMAP 2 assays, we developed software specific for SMAP 2 primer design. With these new tools, a high-precision and rapid DNA amplification technology becomes available to aid in pharmacogenomic research and molecular-diagnostics applications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17322893     DOI: 10.1038/nmeth1007

Source DB:  PubMed          Journal:  Nat Methods        ISSN: 1548-7091            Impact factor:   28.547


  50 in total

1.  Implications of direct amplification for measuring antimicrobial resistance using point-of-care devices.

Authors:  M R Williams; R D Stedtfeld; H Waseem; T Stedtfeld; B Upham; W Khalife; B Etchebarne; M Hughes; J M Tiedje; S A Hashsham
Journal:  Anal Methods       Date:  2017-01-31       Impact factor: 2.896

2.  Isothermal single nucleotide polymorphism genotyping and direct PCR from whole blood using a novel whole-blood lysis buffer.

Authors:  Sylvia T Victor; Alexander Lezhava; Takefumi Ishidao; Ryuta Endo; Yasumasa Mitani; Yoshihiro Kawaoka; Yoshihide Hayashizaki
Journal:  Mol Diagn Ther       Date:  2009-12-01       Impact factor: 4.074

3.  Rapid detection of haptoglobin gene deletion in alkaline-denatured blood by loop-mediated isothermal amplification reaction.

Authors:  Mikiko Soejima; Kouichi Egashira; Hiroyuki Kawano; Atsushi Kawaguchi; Kimitaka Sagawa; Yoshiro Koda
Journal:  J Mol Diagn       Date:  2011-05       Impact factor: 5.568

Review 4.  Toward integrated molecular diagnostic system (i MDx): principles and applications.

Authors:  Seung-Min Park; Andrew F Sabour; Jun Ho Son; Sang Hun Lee; Luke P Lee
Journal:  IEEE Trans Biomed Eng       Date:  2014-05       Impact factor: 4.538

5.  Degraded DNA may induce discordance of KRAS status between primary colorectal cancer and corresponding liver metastases.

Authors:  Yuka Kaneko; Hidekazu Kuramochi; Go Nakajima; Yuji Inoue; Masakazu Yamamoto
Journal:  Int J Clin Oncol       Date:  2013-01-09       Impact factor: 3.402

6.  Usefulness of peptide nucleic acid (PNA)-clamp smart amplification process version 2 (SmartAmp2) for clinical diagnosis of KRAS codon 12 mutations in lung adenocarcinoma: comparison of PNA-clamp SmartAmp2 and PCR-related methods.

Authors:  Takuya Araki; Kimihiro Shimizu; Katsunori Nakamura; Tomonori Nakamura; Yasumasa Mitani; Kyoko Obayashi; Yukiyoshi Fujita; Seiichi Kakegawa; Yohei Miyamae; Kyoichi Kaira; Takefumi Ishidao; Alexander Lezhava; Yoshihide Hayashizaki; Izumi Takeyoshi; Koujirou Yamamoto
Journal:  J Mol Diagn       Date:  2009-12-10       Impact factor: 5.568

7.  Direct and rapid genotyping of SLCO1B1 388A>G and 521T>C in human blood specimens using the SmartAmp-2 method.

Authors:  Kenta Yoshida; Junichi Takano; Yuri Ishizu; Alexander Lezhava; Ichiro Ieiri; Kazuya Maeda; Yoshihide Hayashizaki; Yuichi Sugiyama
Journal:  AAPS J       Date:  2013-03-08       Impact factor: 4.009

8.  Mutation detection of epidermal growth factor receptor and KRAS genes using the smart amplification process version 2 from formalin-fixed, paraffin-embedded lung cancer tissue.

Authors:  Yohei Miyamae; Kimihiro Shimizu; Yasumasa Mitani; Takuya Araki; Yuki Kawai; Masaru Baba; Seiichi Kakegawa; Masayuki Sugano; Kyoichi Kaira; Alexander Lezhava; Yoshihide Hayashizaki; Koujirou Yamamoto; Izumi Takeyoshi
Journal:  J Mol Diagn       Date:  2010-01-21       Impact factor: 5.568

9.  Single-nucleotide polymorphism (c.309T>G) in the MDM2 gene and lung cancer risk.

Authors:  Yasuaki Enokida; Kimihiro Shimizu; Seiichi Kakegawa; Jun Atsumi; Yoshiaki Takase; Yohei Miyamae; Toshiteru Nagashima; Yoichi Ohtaki; Kyoichi Kaira; Noriaki Sunaga; Noriko Yanagitani; Reiko Yoshino; Katsuhiko Tsunekawa; Hitoshi Igai; Mitsuhiro Kamiyoshihara; Kengo Usui; Alexander Lezhava; Yoshio Tomizawa; Toshihisa Ishikawa; Masami Murakami; Yoshihide Hayashizaki; Izumi Takeyoshi
Journal:  Biomed Rep       Date:  2014-06-26

10.  Analysis of cancer mutation signatures in blood by a novel ultra-sensitive assay: monitoring of therapy or recurrence in non-metastatic breast cancer.

Authors:  Zhenbin Chen; Jinong Feng; Carolyn H Buzin; Qiang Liu; Lawrence Weiss; Kemp Kernstine; George Somlo; Steve S Sommer
Journal:  PLoS One       Date:  2009-09-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.